Figure 1From: Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG) Cumulative incidences of aGVHD (Figure 1 -A) and cGVHD (Figure 1 -B) in 508 patients who underwent sibling identical allo-HSCT and CSA/MTX/MMF GVHD prophylaxis. Back to article page